FDA Postpones Approval Of Novo Nordisk Diabetes Drugs; Reports Focus On Stocks, Not H

admin

Administrator
Joined
Jun 17, 2007
Messages
66,217
Reaction score
0
Points
36
Age
50
Location
Canada
Novo Nordisk is the star of today's health news right now, because the Food and Drug Administration didn't approve two of their new diabetes drugs as expected. But practically all headlines and articles are focused on one thing: What this means for the value of Novo Nordisk shares. Am I crazy, or should the failure a massive diabetes drug manufacturer to properly test prescription drugs before putting them on the market be of concern to a wider audience than shareholders? More »

FDA Postpones Approval Of Novo Nordisk Diabetes Drugs; Reports Focus On Stocks, Not Health is a post from Blisstree - Get tips on healthy living, work outs, wellness & health food recipes. Advice & news on mental health & healthcare..

q2Bu6w9FS5s
 
Back
Top